In the CLL context, it was hypothesized that only chemokines, but not BCR signals, trigger JAK protein tyrosine kinases that boost full BTK activity in terms of integrin activation [60]. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.